Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.

Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Abstract Text:

Neurohormonal activation may provide a pathophysiological link between acute myocardial infarction and chronic congestive heart failure, and modulation of neurohormonal activity may be an important therapeutic target in these conditions. Plasma neurohormones were studied in 55 patients with acute myocardial infarction. Angiotensin II, noradrenaline and ANP were elevated in the early phase but tended to normalize during the first week in patients without signs of heart failure. In patients with heart failure angiotensin II and noradrenaline remained elevated for 1 month and ANP for 4-6 months. During head-up tilt, angiotensin II and noradrenaline increased most in patients with heart failure. In patients with a first myocardial infarction there was a positive correlation between sustained neurohormonal activity and infarct size. Almost complete suppression of plasma ACE activity was achieved within 30 min in 48 patients treated with intravenous enalaprilat, initiated within 24 h from the onset of infarction. The drug was tolerated in dosages of 1.0-1.2 mg given over 1-2h. Patients with systolic blood pressure between 100 and 110 mmHg incurred a greater risk of hypotension than those with higher blood pressure at baseline. Tolerance was not worse among patients treated with intravenous diuretics, metoprolol or nitroglycerin. A total of 98 patients were randomized to treatment with enalapril or placebo, initiated within 24 h from onset of infarction and continued for 4-6 months. During treatment there were no significant differences in plasma levels of angiotensin II, aldosterone, ANP or catecholamines between groups. Echocardiographic recordings were performed in 28 patients. Among patients on placebo there was a positive correlation between plasma levels of noradrenaline at days 5-7 and the increase in left ventricular volumes during the study period, and an inverse correlation between plasma aldosterone at days 5-7 and the increase in left ventricular ejection fraction during the study. No such correlation was found among patients on enalapril. ANP levels at 1 month correlated inversely with the left ventricular ejection fraction at the same time. Plasma neurohormones were measured in 223 patients with mild or moderately severe chronic heart failure, randomized to treatment with ramipril or placebo for 3 months. There was wide variation in hormone levels. Noradrenaline and aldosterone correlated inversely with exercise duration at baseline. Noradrenaline correlated positively with the degree of symptoms. Aldosterone and ANP were reduced with ramipril compared with placebo. Noradrenaline was reduced among patients with baseline levels in the highest tertile. Plasma hormones were also measured at peak exercise in 54 patients. Hormonal levels at rest correlated strongly with those at peak exercise.(ABSTRACT TRUNCATED AT 400 WORDS)

Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Publishing Authors By Initials

For similar circulatory and respiratory physiology: cardiovascular physiology: cardiovascular physiologic processes: ventricular function: ventricular function, left research abstracts see: circulatory and respiratory physiology: cardiovascular physiology: cardiovascular physiologic processes: ventricular function: ventricular function, left research

PUBMED ID PMID:

MEDLINE DATE:

Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Blood pressure. Supplement

VOLUME: 1

Page Numbers: 1-45

Journal Abbreviation:

ISSN: 0803-8023

DAY: 26

MONTH: 02

YEAR: 1995

Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9300787

Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Keywords Mesh Terms:

KEYWORDS: Ventricular Function, Left

MESH TERMS: drug effects

Chemical & Substance for Abstract: Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Information

Substance Name: Peptidyl-Dipeptidase A

Registry Number: EC 3.4.15.1

Grant and Affiliation Information for Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.

AFFILIATION: Department of Medicine, Ostra Hospital Faculty of Medicine, Göteborg University, Sweden.

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Blood Press Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure With special reference to treatment with angiotensin converting enzyme inhibitors Related Publications

• A nonafluoro nucleoside as a sensitive (19)f NMR probe of nucleic Acid conformation.
• Adenomatosis of sheep's lungs; experimental transmission.
• CT for assessing ventricular remodeling: is it ready for prime time?
• Counterpoint: Sympathetic nerve activity does not influence cerebral blood flow.
• Immunological problems in paratuberculosis.
• Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.
• Lacrimal sac plugging caused by Aspergillus fumigatus.
• Last Word on Point:Counterpoint: Sympathetic nervous activity does/does not influence cerebral blood flow.
• Nanometer distance measurements on RNA using PELDOR.
• Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
• Rigid spin-labeled nucleoside C: a nonperturbing EPR probe of nucleic acid conformation.
• Session 17. Formation, composition, and detection of habitable extrasolar planets.
• Single base interrogation by a fluorescent nucleotide: each of the four DNA bases identified by fluorescence spectroscopy.
• Site-specific incorporation of nitroxide spin-labels into 2'-positions of nucleic acids.
• The polymorphous light eruption-severity assessment score does not reliably predict the results of phototesting.
• Therapeutic approaches for prion and Alzheimer's diseases.
• Tuberculosis in Iceland: epidemiological studies.
• Vaccination against paratuberculosis (Johne's disease).
• Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow.
• [Experiences from and views on a group practice]
• [The practice guideline 'Acne' (second revision) from the Dutch College of General Practitioners; a response from the perspective of dermatology]